News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Carl Elliott, The New York Times | 05.26.2015
Untitled Document

If you want to see just how long an academic institution can tolerate a string of slow, festering...

By Maria Petrakis, Bloomberg | 05.25.2015
Untitled Document

Making babies is a business as well as a way of life for father-of-eight Kostas Pantos.

As founder...

By Adam Rutherford, The Guardian | 05.24.2015
Untitled Document

Sometimes I get asked if I’m related to the great physicist Ernest Rutherford. His discoveries about the atomic...

By Glosswitch, New Statesman | 05.22.2015
Untitled Document

Surrogacy is not a new idea; indeed, there is a precedent in the book of Genesis, with the...

By Carey Goldberg, WBUR | 05.22.2015
Untitled Document

It was standing room only in the Harvard Medical School auditorium last week, the...

By Robert Pollack, Science | 05.22.2015
Untitled Document

In calling their perspective “A prudent path forward for genomic engineering and germline gene modification” (3 April, p...

By Michael Cook, MercatorNet | 05.21.2015
Untitled Document

The single most controversial development in biology in 2015 is a relatively cheap, easily manipulated technology for modifying...

By David Dobbs, BuzzFeed | 05.21.2015
Untitled Document

“Success in sight: The eyes have it!” Thus the scientific journal Gene Therapy greeted the news, in 2008...